Trends in Immunology
ReviewCytosolic DNA sensors regulating type I interferon induction
Section snippets
Type I interferon (IFN) response to DNA
The innate immune system responds to the presence of pathogens or danger by recognising pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) respectively, leading to altered gene expression, immune effector mechanisms and ultimately a return to homeostasis. PAMPs and DAMPs are detected by several classes of host pattern recognition receptors (PRRs) including the Toll-like receptors (TLRs), RIG-like receptors (RLRs), NOD-like receptors (NLRs) and C-type
Signalling components involved in the cytosolic DNA response
Although the specific receptor molecules involved in triggering TLR9-independent DNA sensing pathways were unknown until recently, studies examining the cellular responses induced by transfecting different types of DNA molecules into cells, or infecting cells with DNA viruses, have uncovered several signalling proteins functioning downstream of DNA sensors that are required for cytosolic DNA responses (Figure 1). Apart from the transcription factors nuclear factor (NF)-κB and IFN regulatory
Novel intracellular DNA sensors for IFN induction
Neither TBK1 nor STING directly recognises DNA in the cytosol. Rather, upstream cytosolic DNA sensors have recently been described, which are proposed to have the capacity to bind directly to DNA, and engage signalling pathways converging on NF-κB and IRF activation, leading to type I IFN induction (Figure 1). These sensors display some selectivity in terms of cell type, the pathogens sensed, and the exact nature of the DNA ligand tested (Table 1). However, work to date suggests that it is
Negative regulation of intracellular DNA sensing pathways
The inappropriate induction of type I IFNs leads to the onset of such autoimmune disorders as SLE and Aicardi–Goutieres syndrome (AGS). The detrimental effects of dysregulated type I IFN production is underscored by the fatal encephalopathy induced by overproduction of IFN-α in AGS [43]. Furthermore, irf3 or ifnαβR deletion can reverse the lethal phenotype of autoimmune disorders in mice 44, 45, 46. Accordingly, inappropriately generated self nucleic acid must be cleared efficiently to prevent
Viral evasion of innate DNA sensing mechanisms
Most PRRs identified to date are subject to targeting by viral evasion mechanisms [66], and this is also becoming apparent for some of the novel cytosolic DNA sensors (Table 2). Before the discovery of DNA sensors, it was already appreciated that multiple viral mechanisms exists to antagonise TBK1 signalling (reviewed in [66]), however, it has also now been shown that some viruses also target the novel DNA sensors more directly. For example, murine CMV encodes a receptor-interacting protein
DNA sensing: future perspectives and outstanding questions
Understanding of innate intracellular DNA sensing pathways has advanced rapidly in recent years. As described above, a number of candidate sensors of intracellular DNA have now been described. However, key questions remain to be addressed. Whether all of the current described DNA sensors are actually true receptors requires clarification. For example, specific regulation of IFN-β by LRRFIP1 independently of any role in TNF-α induction coupled with no role in IRF3 or p65 activation points to a
Acknowledgements
The authors are supported by Science Foundation Ireland.
References (70)
- et al.
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response
Immunity
(2006) The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation
Immunity
(2008)IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection
Cell Host Microbe
(2011)The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
Blood Cells Mol. Dis.
(2004)Trex1 prevents cell-intrinsic initiation of autoimmunity
Cell
(2008)Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
J. Autoimmun.
(2003)Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions
Am. J. Pathol.
(2001)A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection
Immunity
(2005)The HIN-200 family: more than interferon-inducible genes?
Exp. Cell Res.
(2005)A Toll-like receptor recognizes bacterial DNA
Nature
(2000)
Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation
J. Exp. Med.
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes
J. Exp. Med.
Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation
J. Immunol.
Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways
J. Leukoc. Biol.
Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways
J. Immunol.
Induction of type I interferons by bacteria
Cell Microbiol.
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA
Nat. Immunol.
TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections
J. Immunol.
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Nature
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Nature
MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals
Mol. Cell. Biol.
ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization
Proc. Natl. Acad. Sci. U.S.A.
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Nature
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis
Proc. Natl. Acad. Sci. U.S.A.
The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1
Nat. Immunol.
The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides
Infect. Immun.
Identification and characterization of a loss-of-function human MPYS variant
Genes Immun.
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Nature
Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1
J. Virol.
Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules
Proc. Natl. Acad. Sci. U.S.A.
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors
J. Immunol.
DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB
EMBO Rep.
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate
Nat. Immunol.
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway
Cell
Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells
Proc. Natl. Acad. Sci. U.S.A.
Cited by (172)
Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy
2024, Molecular Therapy Nucleic AcidsRadiation-induced non-targeted effect of immunity provoked by mitochondrial DNA damage triggered cGAS/ AIM2 pathways
2022, Radiation Medicine and ProtectionIn vitro and in vivo correlation of skin and cellular responses to nucleic acid delivery
2022, Biomedicine and PharmacotherapyThe identification of a shorter cyclic GMP-AMP synthase gene from chickens and bioinformatics analysis of its potential signaling in IFN regulation
2022, Developmental and Comparative ImmunologyEvaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132
2024, Lupus Science and Medicine